POSTER PRESENTATIONS
GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Abstracts will be accepted until September 6, 2016; slots fill up quickly so submit yours online ASAP!
 

Biomarker Summit Europe 2016
Venue: Berlin, Germany
Date: 5 - 7 October, 2016

Dear Colleague,

GTCbio would like to invite you to attend our Biomarker Summit Europe 2016 on October 5-7, 2016  in Berlin, Germany!

The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing,
companion diagnostics, the health economics value of biomarkers, reimbursement environment, and perspective on cell free biomarkers for disease diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.

Biomarker Summit Europe 2016 consists of four conferences including joint sessions:

Conference: 10th Biomarkers in Drug Discovery & Development
Conference: 5th Biomarkers in Diagnostics
Conference: Biomarkers in Clinical Development & Clinical Trials
Conference: Cell-Free Biomarkers


10th Biomarkers in Drug Discovery & Development
I. Biomarker Discovery & Identification Strategies
II. Biomarkers from Qualification to Validation
III. Biomarkers of Translational Medicine: Safety, PK/PD, & Efficacy
IV. Biomarkers in Personalized Medicine
V. Big Data Analytics for Biomarkers Development

5th Biomarkers in Diagnostics
I. Novel Diagnostic Technologies
II. New Diagnostic Biomarkers & Their Development
III. Companion Diagnostics Development & Commercialization 
IV. Joint Session: Clinical Utility of Diagnostic & Screening Biomarkers
V. Joint Session: Health Economics Value of Biomarkers & Reimbursement Environment
VI. Joint Session: Regulatory Considerations in Clinical Dx

Biomarkers in Clinical Development & Clinical Trials
I. Joint Session: Clinical Utility of Diagnostic & Screening Biomarkers
II. Joint Session: Health Economics Value of Biomarkers & Reimbursement Environment
III. Joint Session: Regulatory Considerations in Clinical Dx
IV. Clinical Trials & Developments
V. Biomarkers & Surrogate Endpoints for Clinical Trials

Cell-Free Biomarkers

I. Circulating Biomarkers Overview
II. Cell-free DNA & RNA Technologies & Their Platforms
III. Clinical Applications of Cell-Free DNA & RNA in Disease Diagnosis & Management
IV. New Developments in Cell-Free Biomarkers
V. Exosomes in Diagnosis, Treatment, & Disease Management



We hope to see you there!

Best regards,

The 2016 Advisory Committee

 

2016 Scientific Advisory Board
Mohammad Afshar, Ariana Pharma
Catherine Alix-Panabières, University Medical Center of Montpellier
John Beeler, Inivata
Christoph Borchers, University of Victoria
Richard Buller, Pfizer
Daniel Chelsky, Caprion Proteomics
Sandra Close (Kirkwood), GenEngine Biotechnology
Kevin Cox, Imanova
Corina Dana Dota, AstraZeneca
Manfred Dietel, Charité – Universitätsmedizin Berlin
Anka Ehrhardt, Bristol-Myers Squibb
Laura Elnitski, National Human Genome Research Institute
Joseph Ferrara, Boston Healthcare
Michael Heller, University of California San Diego
Franz Hessel, SRH University Berlin
Ulrich Hoffmueller, Epiontis GmbH
Scott Kennedy, Novartis
Kathy Kerr, P&G
Hans Lehrach, Max Planck Institute for Molecular Genetics
Douglas Macdonald, CHDI Foundation
Pierluigi Mauri, Institute for Biomedical Technologies
Robert McMaster, University of British Columbia
Stephen Pennington, University College Dublin
Bruce Quinn, FaegreBD Consulting Washington
Heinrich Roder, Biodesix
Sabita Sankar, Biodesix
Philipp Schatz, Metanomics Health GmbH
Nicole Schneiderhan-Marra, University of Tuebingen
Andreas Schuppert, RWTH Aachen University; Bayer Technology Services GmbH
Laszlo Takacs, Biosystems International Kft. Hungary
Denise Uettwiller-Geiger, John T. Mather Memorial Hospital
Alain van Gool, Netherlands Organization for Applied Scientific Research
Miro Venturi, Roche
Lars Verschuren, Netherlands Organization for Applied Scientific Research
Marion Wiesmann, Novartis
Penny Wilson, Innovate UK
Diane Wuest, GNS Healthcare

 

CORPORATE SPONSORS
     
 
     
MEDIA PARTNERS
 
     
     
journal of rheumatology